5:29 PM ET
Earnings Call
▶ Call
BioStem Technologies Earnings Call: Key Takeaways
BioStem is undergoing a high-stakes transition, prioritizing a $10-$12 million cost reduction and in-house manufacturing to offset significant Q3 losses and a dwindling cash position.